Insider Trading News

Twist Bioscience Corp CEO Emily M. Leproust sells $619,193 of TWST

By Insider Stock Trader Newsroom1 min readInsider Stock Trader
Twist Bioscience Corp CEO Emily M. Leproust sells $619,193 of TWSTTwist Bioscience Corp CEO Emily M. Leproust sells $619,193 of TWST

An open-market sale on Nov 3, reported to the SEC on Nov 5, not marked as part of a 10b5-1 plan. Information only, not investment advice.

Twist Bioscience Corp's chief executive officer, Emily M. Leproust, sold 4,573 shares of the company's stock on the open market on Nov 3. The sale, at an average of $135.40 a share, comes to $619,193.

The filing does not mark the sale as made under a Rule 10b5-1 trading plan. After the trade, the filing lists 558,187 shares held.

Five Twist Bioscience Corp insiders sold on the open market within 14 days, a pattern known as a cluster sell. The trade was reported within two business days, as Section 16 requires.

The numbers below are taken from the Form 4 as filed with the SEC.

The sale
CompanyTwist Bioscience Corp (TWST)
InsiderEmily M. Leproust
RoleCEO
TransactionOpen-market sale (code S)
Shares4,573
Average price$135.40
Value$619,193
Trade dateNov 3, 2026
Filed with the SECNov 5, 2026, 4:05 PM ET
Shares held after558,187
OwnershipDirect
Rule 10b5-1 planNot marked in the filing

Open the full breakdown of this TWST trade

View the Form 4 on SEC.gov

See where several insiders traded together · Browse the insider trading newsroom

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.